MEDGm vs Gala GLP-1 for weight loss
MEDGm and Gala GLP-1 side by side: what each costs as your dose rises, which medications each prescribes, and the terms behind the price.
By the RxLineup editorial team · Fact-checked against provider sites and FDA labels · Updated
Only providers that pay us appear in our rankings and reviews, and we’re paid when you sign up through our links. How we make money
- Safety: GLP-1 medications carry a boxed warning for thyroid C-cell tumors. Read before you start
Higher score
MEDGm
Rated 9.0 out of 10, Excellent
From $299/mo
Tirzepatide $269/mo
Gala GLP-1
Rated 8.8 out of 10, Excellent
From $129/mo
Tirzepatide $179/mo
The verdict
Gala GLP-1 charges less for compounded semaglutide ($129/mo vs $169/mo, 12 mo prepaid); Gala GLP-1 charges less for compounded tirzepatide ($179/mo vs $269/mo, 12 mo prepaid). Only MEDGm offers oral compounded GLP-1, Zepbound, Wegovy and the Wegovy pill. MEDGm scores higher overall (9.0 vs 8.8), with its widest lead on clinical care (9.5 vs 8.5).
Choose MEDGm if…
You want the option of oral compounded GLP-1, Zepbound, Wegovy or the Wegovy pill and a better clinical care score (9.5 vs 8.5).
Choose Gala GLP-1 if…
You want compounded semaglutide for $129/mo, compounded tirzepatide for $179/mo and a better price-and-value score (8.8 vs 8.0).
What’s different
The six places where MEDGm and Gala GLP-1 differ for weight loss, from the prices and terms each publishes.
| Difference | MEDGm | Gala GLP-1 |
|---|---|---|
| Compounded semaglutide | $169/mo | $129/mo |
| Compounded tirzepatide | $269/mo | $179/mo |
| Oral compounded GLP-1 | $239/mo | Not offered |
| Zepbound | Offered; price not published | Not offered |
| Wegovy | Offered; price not published | Not offered |
| Wegovy pill | Offered; price not published | Not offered |
Both offer Ozempic.
Head to head
| Feature | MEDGm review | Gala GLP-1 review |
|---|---|---|
| Overall score | 9.0/10 Higher | 8.8/10 |
| Starting price | $299/mo | $129/mo Lower |
| Compounded semaglutide | $169/mo billed $2,028 for 12 months | $129/mo Lower |
| Compounded tirzepatide | $269/mo billed $3,228 for 12 months | $179/mo Lower |
| Brand-name options | Zepbound, Wegovy, Wegovy pill, Ozempic | Ozempic |
| Same price at every dose | Yes | Yes |
| Membership | None | None |
| Insurance | – | Self-pay |
| Refunds | 100% refund if the provider determines you don’t qualify | Refund of remaining charges if you are medically disqualified |
| Availability | All 50 states and DC (its terms say some medications may not be available in every state) | Licensed providers in all 50 states |
| Next step | Visit MEDGm for MEDGm (opens in a new tab) | Visit Gala GLP-1 for Gala GLP-1 (opens in a new tab) |
– Not published by the provider.
Scores compared
Both programs are scored out of 10 on the same five weighted criteria. How we rate
MEDGmGala GLP-1
-
Price & value 30%
-
Clinical care 25%
-
Medication options 20%
-
Transparency 15%
-
Experience 10%
MEDGm pros and cons
Strengths
- Lab work and metabolic report included
- Unlimited clinician access by video or chat
- Same price at any dose
- Compounded tablets plus brand-name Zepbound, Wegovy and Ozempic
- Pharmacies named; HSA/FSA eligible
Drawbacks
- Month to month is $299 for semaglutide after the first month
- No refund for the current month on monthly plans
- Brand-name medication prices not published
- Cancel at least 72 hours before renewal
Gala GLP-1 pros and cons
Strengths
- Semaglutide from $129/mo, tirzepatide from $179/mo, all doses
- No membership fee; coaching and app included
- Free shipping, about 7 days to your door
- All 50 states
Drawbacks
- Prices differ across Gala pages ($129, $179, $199)
- Plan terms shown only at checkout
- No refund on cancellation unless medically disqualified
- Video is usually only for the first visit
Safety
One of these treatments carries an FDA boxed warning, the strongest warning on a label: GLP-1 medications.
- SemaglutideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- TirzepatideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- Compounded GLP-1sCompounded; not FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- ZepboundFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- WegovyFDA-approved for long-term weight reduction (adults, and children 12 and older)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Wegovy pillFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- OzempicFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Not medical advice. A licensed clinician decides whether a treatment is right for you; read the full prescribing information before you start.
Not sure which program fits?
Answer five quick questions about budget, medication and insurance, and we’ll rank the programs for you. No email or sign-up needed.